Susanne

Shareholder

(703) 677-3006

shopkins@rmsc2.com

Key Practice Areas: Life sciences, chemical, biotechnology, and medical device patent practice; Due Diligence, and Technology Transactions.

Susanne Hopkins is a registered patent attorney and is a Shareholder with Roberts Mlotkowski Safran Cole & Calderon.  Susanne has been practicing intellectual property (IP) law for more than 20 years and focuses her practice on technology areas primarily including biotechnology, biochemistry, pharmaceuticals, small molecules, biologics, biosimilars, genetics, diagnostics, bioinformatics, nanotechnology, drug design, materials, chemistry, polymer chemistry, immunology, medical device, and microfluidics.

Susanne’s research experience at Yale University Medical Center, George Washington University Medical Center and Genex Corporation, as well as her in-house counsel experience at LifeNet Health, uniquely positions her to take a business-minded approach to the practice of intellectual property law.  She excels at managing and leveraging IP capital to maximize value and competitive advantage.  Susanne counsels a wide range of clients, from start-ups and emerging growth companies to multi-national corporations, including pharmaceutical companies, medical device companies, health care providers, universities, government contractors, and high-tech companies, on a wide variety of IP issues.

Susanne’s experience includes client counseling; managing domestic and global IP portfolios; conducting due diligence investigations; conducting post-grant proceedings before the United States Patent and Trademark Office including inter partes review, reexamination, and reissue proceedings; monitoring competitive activity; drafting and negotiating transactional agreements; preparing legal analysis; analyzing resource allocation; in- and out-licensing; developing IP strategies; and procuring domestic and foreign patents, on behalf of her clients.  She has conducted numerous due diligence investigations, including patentability, freedom-to-operate, non-infringement and validity analysis on behalf of clients seeking to in-license or acquire technology, launch new products, enter into collaborative agreements, attract financing, or acquire companies.

Susanne enjoys writing articles and lecturing start-ups, clients, and students, on various intellectual property topics.

Career highlights include:

  • Obtaining favorable outcomes for a number of clients challenging the validity of competitor patents in multiple inter partes review proceedings.
  • Managing complex tech-transfer matters for major, national and international hospital systems.
  • Conducting several major due diligence investigations on behalf of a global pharmaceutical company seeking to acquire a target company’s IP.
  • Instrumental in growing a $2 million company into a $70+ million company based on developing, manufacturing and marketing value-added products by implementing IP strategies; procuring IP including patents and trademarks; leveraging IP to maximize value by in- and out-licensing; and entering into collaborative agreements with strategic partners.
  • Procuring numerous patents for a company that successfully sued an infringer where the subject patents were held valid and infringed, and the company was awarded a multi-million dollar judgment.
  • Successfully negotiating a complex joint research and development, marketing and manufacturing agreement to develop, manufacture and market a product between three companies including a global pharmaceutical/medical device/health care company.

Legal History: Partner, Vorys, Sater, Seymour and Pease, Washington, D.C.; Partner, The Nath Law Group, Alexandria, VA; In-House Counsel, LifeNet Health, Virginia Beach, VA.

Education: State University of New York at Buffalo (B.A., Molecular Biology); George Mason School of Law (J.D., 1991).

Admitted: 1991, Virginia; 2012, Washington, D.C.; 1987, registered to practice before the United States Patent and Trademark Office.

Memberships: American Intellectual Property Law Association; Vistage™.